SBIR Phase I: Membrane-Permeable Nano-Materials for Cell Reprogramming Solutions

Award Information
Agency:
National Science Foundation
Branch
n/a
Amount:
$150,000.00
Award Year:
2012
Program:
SBIR
Phase:
Phase I
Contract:
1214943
Award Id:
n/a
Agency Tracking Number:
1214943
Solicitation Year:
2012
Solicitation Topic Code:
NM
Solicitation Number:
n/a
Small Business Information
454 North 34th Street, Suite 100, Seattle, WA, 98103-8602
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
Y
Duns:
968319819
Principal Investigator:
Andranik Andrew Aprikyan
(206) 300-4774
aaa@stemgenics.com
Business Contact:
Andranik Andrew Aprikyan
(206) 300-4774
aaa@stemgenics.com
Research Institute:
Stub




Abstract
This Small Business Innovation Research (SBIR) Phase I project proposes to develop novel superparamagnetic biocompatible cell-penetrant bioactive nanoparticles for reprogramming human somatic cells and generation of pluripotent stem cells with intact genomes. To demonstrate technical feasibility, the plan is to use the most promising routes for high-density functionalization of nanoparticles. The resultant superparamagnetic biocompatible bioactive nanoparticles (SPBBN) will be evaluated for their efficiency in cell reprogramming and generation of induced pluripotent stem cells. The goal is to obtain the proof-of-concept data documenting that SPBBN produced by coupling cell penetrant and biologically active molecules can be used successfully for generation of pluripotent stem cells and other cell types with intact genomes, thereby suitable for research and preclinical/clinical applications. The broader impact/commercial potential of this proposed project is the production of superparamagnetic biocompatible bioactive nanoparticles (SPBBN) capable of penetrating through cell membrane and delivering biologically active molecules to reprogram cells into stem or more specialized cells while preserving the cell genome intact. Because this innovative methodology does not use DNA or RNA, the resultant human pluripotent stem cells (PSCs) and/or their progeny will have an intact genome, and, therefore, will preserve their normal gene expression profiles. There is a lack of alternative, effective non-integrating technology; a vast majority of research laboratories in academia and private centers generate human PSCs using viral delivery of reprogramming factors. Furthermore, advances in personalized medicine are also hindered by the absence of effective cell reprogramming and generation of safe PSCs and their progeny. The company's unique approach offers cell membrane-penetrant bioactive nanomaterials for cell reprogramming solutions focused on cellular therapy for academic research and pharmaceutical preclinical and clinical applications.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government